No Data
No Data
Recursion's All-Stock Acquisition of Exscientia Plc (EXAI): NVIDIA-Backed Merger to Revolutionize AI-Driven Drug Discovery
Exscientia Set for Strategic Acquisition by Recursion
Recursion, Exscientia Seek Support for Merger Ahead of Special Meeting
Exscientia | 6-K: Report of foreign private issuer (related to financial reporting)
Express News | Exscientia Announced Three Abstracts To Be Presented At The EORTC-NCI-AACR Symposium 2024
Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024
No Data
No Data